More generally, anti-inflammatory actions of ApN in CNS could constitute a means of combating various mental disorders and brain diseases associated with deleterious chronic inflammation or exacerbated inflammatory response, such as depression, anxiety, schizophrenia, stroke, multiple sclerosis, Parkinson's disease, and Alzheimer's disease. This evidence concerns the gene ANPEP and depressive symptom measurement.